Target intelligence / Profile preview

Adipose Tissue Metabolism (N/A)

Target
N/A
Molecular classification
Metabolic Process, Endocrine Function, Cellular Metabolism
01

Overview

Adipose tissue metabolism encompasses the biochemical and cellular processes governing energy storage, mobilization, and utilization within adipose (fat) tissue. It involves lipogenesis (fatty acid synthesis and triglyceride storage), lipolysis (triglyceride breakdown into free fatty acids and glycerol), and the secretion of adipokines, which influence whole-body energy balance, glucose homeostasis, and metabolic health. Dysregulation of adipose tissue metabolism is a key factor in the development of obesity, type 2 diabetes, and cardiovascular disease. Adipose tissue also contributes to thermogenesis via specialized cells that express uncoupling protein 1 (UCP1).

Other names
Fat MetabolismAdipocyte MetabolismLipid Metabolism in Adipose TissueAdipose Tissue Remodeling
02

Mechanism of action

Varies widely depending on the specific drug. Examples: - Thiazolidinediones: PPARγ agonists, increasing insulin sensitivity in adipose tissue. - Metformin: Primarily reduces hepatic glucose production, but also influences adipose tissue metabolism. - Orlistat: Inhibits pancreatic lipase, reducing dietary fat absorption and indirectly affecting adipose tissue lipid storage. - Beta-adrenergic agonists: Stimulate lipolysis in adipose tissue through activation of beta-adrenergic receptors.

03

Biological functions

Energy StorageEnergy MobilizationThermogenesisEndocrine SignalingRegulation of Energy BalanceGlucose HomeostasisInflammationImmune Function
04

Disease associations

ObesityType 2 Diabetes MellitusMetabolic SyndromeCardiovascular DiseaseInsulin ResistanceInflammation
05

Safety considerations

Dysregulated adipose tissue metabolism can lead to insulin resistance and type 2 diabetes.Excessive lipolysis can lead to elevated free fatty acid levels and lipotoxicity.Chronic inflammation in adipose tissue can contribute to systemic inflammation and cardiovascular disease.Certain drugs targeting adipose tissue metabolism can have side effects such as weight gain, fluid retention, or liver toxicity.
06

Interacting drugs

Thiazolidinediones (e.g., Pioglitazone)

7 more in the full profile.

07

Biomarkers

Leptin levelsAdiponectin levelsResistin levelsFree fatty acid levelsTriglyceride levelsInsulin levelsGlucose levelsHbA1cInflammatory markers (e.g., TNF-α, IL-6)

Beyond the preview

Go deeper on Adipose Tissue Metabolism (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipose Tissue Metabolism (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call